by The aesthetic injectables market has seen tremendous growth over the past decade driven by the rise in demand for non-invasive aesthetic procedures. Aesthetic injectables such as facial injectables, breast implants, buttock augmentation, and other dermal fillers are commonly used in procedures to reduce wrinkles, lift tissues, and enhance appearance through volume restoration or replication. The products harness dermal fillers and neurotoxins that add volume or relax muscles to minimize lines and wrinkles on the face and body.
The Global Aesthetic Injectables Market is estimated to be valued at US$ 19.76 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Aesthetic Injectables are AbbVie, Galderma, Merz Pharma, Teoxane Laboratories, Sinclair Pharma, Suneva Medical, Croma-Pharma GmbH, Luminera Derm, Johnson & Johnson, Revance Therapeutics, Hyaltech Ltd, Bioxis Pharmaceuticals, Prollenium Medical Technologies, SciVision Biotech Inc., and Bloomage BioTechnology Corporation Ltd. Key players like AbbVie and Galderma account for over 45% of the global market share due to their popular brands and wide distribution networks.
The growing demand for Aesthetic Injectables Market Size procedures owing to rising consciousness about physical appearance is fueling market growth. With increasing disposable incomes and growing focus on self-care, people are willing to invest more on aesthetic treatments. This has boosted the sales of various aesthetic injectable products significantly.
Geographic expansion into emerging markets is another key trend. Major players are focusing on regions like Asia Pacific and Latin America which are witnessing rapid development and change in lifestyle. This provides huge opportunities due to growing medical tourism and increasing disposable incomes in these regions
Market Key Trends
One of the major trends in the aesthetic injectables industry is the increasing demand for combination therapies. Many providers are now offering more tailored aesthetic treatment plans combining neurotoxins and dermal fillers. For example, wrinkle treatment using Botox followed by dermal fillers to add volume. This integrated approach provides better aesthetic outcomes. It has become a popular trend especially in advanced markets. Focus on differentiation through new product launches and novel technologies is another key trend to gain market share in the highly competitive aesthetic injectables market.
Porter’s Analysis
Threat of new entrants: The aesthetic injectables market requires significant investment in R&D that deters new players from entering the market.
Bargaining power of buyers: Individual customers have low bargaining power due to limited choice in brands.
Bargaining power of suppliers: Suppliers have strong bargaining power due to proprietary ingredients, manufacturing processes and intellectual property rights.
Threat of new substitutes: Non-invasive procedures like laser treatments pose a threat but are not perfect substitutes for injectables.
Competitive rivalry: Major players compete on brand reputation, innovation and marketing. Strong networks of dermatologists and aesthetic physicians create loyalty to certain brands.
Geographical Regions
North America dominates the aesthetic injectables market accounting for over 30% value share driven by developed healthcare infrastructure and higher patient acceptability for such procedures.
Asia Pacific region is poised to be the fastest growing market rising at a CAGR of over 13% during the forecast period owing to rapidly ageing population, inclination towards youthful aesthetic appeal and rising medical tourism in countries like Thailand, South Korea and India. Rising disposable incomes and growing middle class are key growth factors for Asia Pacific.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
